Eaton Vance Management Edwards Lifesciences Corp Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Eaton Vance Management holds 906,031 shares of EW stock, worth $61.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

906,031

Previous 902,744 0.36%

Holding current value

$61.4 Million

Previous $85.8 Million 12.79%

% of portfolio

0.11%

Previous 0.12%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $270,750 - $352,662	3,287 Added 0.36%	906,031 $74.9 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $36.8 Million - $54.6 Million	425,326 Added 89.09%	902,744 $85.8 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $13.4 Million - $16.9 Million	131,712 Added 38.1%	477,418 $56.2 Million
Q4 2021 Apr 12, 2022	BUY	$106.37 - $130.68 $1.6 Million - $1.97 Million	15,076 Added 4.56%	345,706 $44.8 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $35.2 Million - $43.2 Million	330,630 New	330,630 $42.8 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $40.8 Million - $48.7 Million	-396,484 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $2.69 Million - $3.36 Million	32,045 Added 8.79%	396,484 $41.1 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $2.64 Million - $3.05 Million	33,615 Added 10.16%	364,439 $30.5 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $3.92 Million - $4.99 Million	-54,649 Reduced 14.18%	330,824 $30.2 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $1.45 Million - $1.89 Million	21,615 Added 5.94%	385,473 $30.8 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $14 Million - $18.7 Million	242,637 Added 200.16%	363,858 $25.1 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $917,070 - $1.42 Million	17,498 Added 16.87%	121,221 $22.9 Million
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $2.19 Million - $2.51 Million	-30,572 Reduced 22.76%	103,723 $24.2 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $16,803 - $20,592	273 Added 0.2%	134,295 $29.5 Million
Q2 2019 Aug 16, 2019	BUY	$55.74 - $64.41 $7.47 Million - $8.63 Million	134,022 New	134,022 $24.8 Million
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $6.46 Million - $7.93 Million	-139,295 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $810,306 - $1.03 Million	-17,731 Reduced 11.29%	139,295 $24.3 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $1.03 Million - $1.24 Million	-24,203 Reduced 13.35%	157,026 $22.9 Million
Q1 2018 May 07, 2018	SELL	$37.19 - $47.45 $983,080 - $1.25 Million	-26,434 Reduced 12.73%	181,229 $25.3 Million
Q4 2017 Feb 12, 2018	SELL	$33.79 - $39.39 $583,519 - $680,225	-17,269 Reduced 7.68%	207,663 $23.4 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $8.16 Million - $8.73 Million	224,932	224,932 $24.6 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Edwards Lifesciences Corp Transaction History